Normative data for the Hospital Anxiety and Depression Scale

Acknowledgments The authors would like to thank all those involved in the EpiFunD study for their role in collecting the data used in this study, particularly the principal investigators Gary Macfarlane (University of Aberdeen) and John McBeth (Keele University, and the University of Manchester) who allowed use of the EpiFunD dataset. The EpiFunD study was funded by Arthritis Research UK (formerly the Arthritis Research Campaign), Grant Number: 17552.Peer reviewedPostprin

How to Deal with a Temporary Suspension and Restarting Your Trial : Our Experiences and lessons Learnt

Funding: VUE is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme (project reference 11/129/183). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.Peer reviewedPublisher PD

Verifying participant-reported clinical outcomes : challenges and implications

The parent trials KAT, REFLUX and CATHETER were all funded by the UK NIHR Health Technology Assessment Programme. RECORD was funded by the UK Medical Research Council. Suzanne Breeman and Lynda Constable are joint first authors.Peer reviewedPublisher PD

A randomised controlled trial of the clinical effectiveness and cost-effectiveness of different knee prostheses : the Knee Arthroplasty Trial (KAT)

Peer reviewedPublisher PD

Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs

This report The research reported in this issue of the journal was funded by the HTA programme as project number 11/129/183. The contractual start date was in November 2012. The draft report began editorial review in February 2018 and was accepted for publication in August 2018. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report.Peer reviewedPublisher PD

Surgery for women with endometrioma prior to in vitro fertilisation: proposal for a feasible multicentre randomised clinical trial in the UK

Acknowledgements We thank all clinicians who filled the questionnaire, all patients and their partners who participated in interviews and focus groups, all women who helped to design WP3, theStaff at Aberdeen Fertility Centre who helped in recruiting for the qualitative study, Prof. Graeme McLennan (Director Clinical Trials Unit) and Prof. Shaun Treweek (Health Services Research Unit) in Aberdeen for their valuable suggestions in the design of the proposed trial, Dr Tarek Gelbaya for personal communication and Dr C Tomosseti for personal communication. Funding The study was funded by NHS Grampian pump priming endowment fund (RG14437-12).Peer reviewedPublisher PD

It is unprecedented : trial management during the COVID-19 pandemic and beyond

Funding: UKTMN is funded by the Nuffield Department of Population Health (NDPH) at the University of Oxford. Acknowledgments: We thank Graeme MacLennan, Director of the Centre for Health Care Randomised Trials (CHaRT) for the inspiration for this article and UKTMN members for their input into its content. We also thank the huge clinical trial community, both nationally and internationally, for continuing to run clinical trials in these challenging times, and for regulatory agencies to adapting their processes to enable efficiencies.Peer reviewedPublisher PD